RHYTHM PHARMACEUTICALS, INC. — Director's Dealing 2018

Jun 8, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RHYTHM PHARMACEUTICALS, INC. (RYTM)
CIK: 0001649904
Period of Report: 2018-06-06

Reporting Person: Kelner Simon (Chief Human Resources Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-06-06	Employee Stock Option (right to buy)	$34.89	A	60000	Acquired	2028-06-05	Common Stock (60000)	Direct

Footnotes

F1: The option vests as follows: (1) 25% on June 4, 2019, and (2) the remaining 75% in 12 equal quarterly installments.